Σάββατο 26 Οκτωβρίου 2019


Comorbidities and long-term outcomes in a cohort with myasthenic crisis: Experiences from a tertiary care center
Ajith Sivadasan, Mathew Alexander, Sanjith Aaron, Vivek Mathew, Shalini Nair, Karthik Muthusamy, AT Prabhakar, Rohit N Benjamin, Atif Shaikh, Gideon RynjahAnnals of Indian Academy of Neurology 2019 22(4):464-471 Introduction: There is scarce literature regarding the clinical course, comorbidities and long-term outcomes after myasthenic crisis (MC). The natural history of myasthenia gravis (MG) in this subset remains uncertain. Methods: The study included a cohort admitted with MC (2007–2017) in...
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Hypokalemic quadriparesis: A rare manifestation of dengue fever
Veer Bahadur Singh, Harish KumarAnnals of Indian Academy of Neurology 2019 22(4):519-520
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Myasthenic crisis – Comorbidities, complications, long-term outcomes: The challenges
Jagarlapudi M. K. MurthyAnnals of Indian Academy of Neurology 2019 22(4):472-473
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Identification and in Silico characterization of a novel CASK c.2546T>C (p.V849A) mutation in a male infant with pontocerebellar hypoplasia
Akella Radha Rama Devi, Lokesh Lingappa, Shaik Mohammad NaushadAnnals of Indian Academy of Neurology 2019 22(4):523-524
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Interleukin 18 polymorphisms and its serum level in patients with multiple sclerosis
Hamidreza Jahanbani-Ardakani, Fereshteh Alsahebfosoul, Masoud Etemadifar, Seyed-Hossein AbtahiAnnals of Indian Academy of Neurology 2019 22(4):474-476 Background: Multiple sclerosis (MS) is a chronic demyelinating disorder of central nervous system. Although the definite pathogenesis of MS has not been understood, crucial role of environmental and genetic risk factors has been proposed. Propose: To determine the serum level of interleukin-18 (IL-18) as well as gene polymorphisms of IL-18 (rs1946518,...
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Nonarteritic anterior ischemic optic neuropathy and stroke in young
Nataraja Pillai Venugopal, Sherin Kummararaj, Govindaraj KummararajAnnals of Indian Academy of Neurology 2019 22(4):526-526
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Errors in the diagnosis of stroke-tales of common stroke mimics and strokes in hiding
Sucharita Ray, Kamalesh Chakravarty, Heena Kathuria, Vivek LalAnnals of Indian Academy of Neurology 2019 22(4):477-481 Introduction: Stroke mimics are some of the common causes of misdiagnosis of stroke, with an attendant surfeit of finances and resources. Aim: We attempt to discuss some of the common neurological conditions mimicking stroke in the emergency. Methods: We reviewed the articles in English discussing stroke mimics in the last 5 years of publication. Purpose of the Review: We discuss...
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Lacosamide associated complete heart block in elderly
Indu Ghanshyam Bhana, Mahendra Chourasiya, Soaham Dilip DesaiAnnals of Indian Academy of Neurology 2019 22(4):529-530
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Count of fasciculation in ultrasound can predict the prognosis of amyotrophic lateral sclerosis
Hiroyuki Todo, Katsuya Nishida, Ryuki Ando, Hiroshi Yamasaki, Naonobu Futamura, Itaru FunakawaAnnals of Indian Academy of Neurology 2019 22(4):482-484 Background: Although muscle ultrasound (MUS) is known to facilitate the diagnosis and evaluation of the severity of amyotrophic lateral sclerosis (ALS), the number of fasciculation has been scarcely examined as a predictive marker of the prognosis in ALS. Objective: The objective of this study was to examine the predictive value of fasciculation...
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Prevalence of epilepsy and its association with exposure to Toxocara canis: A community-based, case–control study from rural Northern India
Manish Modi, Rajveer Singh, Manoj Kumar Goyal, Jitender Gairolla, Gagandeep Singh, Vivek Rishi, JS Thakur, RK Sehgal, Vivek Kumar Garg, Niranjan Khandelwal, Parampreet S Kharbanda, S Prabhakar, Vivek LalAnnals of Indian Academy of Neurology 2019 22(4):533-533
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Patients with disorders of consciousness in India: Preliminary results from a pilot survey
Davide Sattin, Nirmal Surya, Caterina Pistarini, Paolo Tonin, Hitav Someshwar, Milena Caputo, Matilde LeonardiAnnals of Indian Academy of Neurology 2019 22(4):485-487 The epidemiological data of Indian patients with disorders of consciousness (DOC), specifically vegetative state and minimally conscious state, have not been investigated. The present study sought to explore the current state of the art in India for patients with DOC promoting a pilot survey. An ad hoc questionnaire was sent to a...
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Partial status epilepticus in cerebral venous sinus thrombosis, initial manifestation of polycythemia vera
Sinan Eliaçik, Ömer Önder Savas, Erdal Komut, Funda Uysal TanAnnals of Indian Academy of Neurology 2019 22(4):536-537
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Isolated and asymmetric basal ganglia involvement in early subacute sclerosing panencephalitis
Mahesh Kamate, Mayank DetrojaAnnals of Indian Academy of Neurology 2019 22(4):488-489
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Juvenile onset niemann-pick type C disease with refractory seizures
Banshi Lal Kumawat, Pankaj Kumar Saini, Chandra Mohan Sharma, Manisha Sharma, LS ManuAnnals of Indian Academy of Neurology 2019 22(4):539-540
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Vertical diplopia: Skew deviation and medullary lesion
Arunmozhimaran Elavarasi, Balachandran ManiAnnals of Indian Academy of Neurology 2019 22(4):490-490
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Short-course self-medication of metronidazole leading to acute toxic encephalopathy and ataxia
Yatin Sagvekar, Virti Shah, Anshu Rohatgi, Neha Pandita, Rahul Sharma, Rajeswari Rajan, Dhrumil ShahAnnals of Indian Academy of Neurology 2019 22(4):543-545
Annals of Indian Academy of Neurology : 2015 - 18(2)
Fri Oct 25, 2019 00:00
Early Exploratory Analysis for Patient-reported Quality of Life and Dosimetric Correlates in Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Low-risk and Intermediate-risk Prostate Cancer: Interim Results from a Prospective Phase II Clinical Trial
Objectives: Given the relative novelty of stereotactic body radiation therapy as a treatment modality low-risk and intermediate-risk prostate cancer, little data exist evaluating dosimetry and its impact on patient-reported quality of life (PR-QOL) metrics. Herein, we present an interim analysis of a phase II clinical trial of PR-QOL and dosimetric correlates. Methods: Patients with biopsy-proven low-risk or intermediate-risk prostate cancer, prostate volume ≤100 cm3, and life expectancy...
American Journal of Clinical Oncology - Current Issue
04:59
Paragangliomas of the Head and Neck: Local Control and Functional Outcome Following Fractionated Stereotactic Radiotherapy
Objectives: To investigate local control and functional outcome following state-of-the-art fractionated stereotactic radiotherapy (FSRT) for paragangliomas of the head and neck. Methods: In total, 40 consecutive patients with paragangliomas of the head and neck received conventionally FSRT from 2003 to 2016 at the Department of Radiation Oncology of the University Hospital Erlangen. Local control, toxicities, and functional outcome were examined during follow-up. In total, 148 magnetic resonance...
American Journal of Clinical Oncology - Current Issue
04:59
Rural-urban Disparities in Lung Cancer Mortality: Missing the Forest for the Trees?
No abstract available
American Journal of Clinical Oncology - Current Issue
04:59
Prognosis and Management of Thick and Ultrathick Melanoma
Objectives: Thick melanomas, defined as ≥4 mm in thickness, represent ~5% of new melanoma diagnoses and have been associated with poor overall survival (OS). Ultrathick melanomas, those lesions ≥8 mm in thickness, have been associated with worse survival. We sought to compare prognostic factors for thick and ultrathick melanoma. Methods: Retrospective analysis of a prospective database of all patients receiving an operation for melanoma, June 2005 to December 2016 was performed. Multivariate...
American Journal of Clinical Oncology - Current Issue
04:59
Determining the Impact of a Cancer Diagnosis on Diabetes Management: A Systematic Literature Review
Objectives: Cancer patients with comorbid diabetes have a 50% increased risk of all-cause mortality compared with cancer patients without diabetes. Less attention to diabetes management (glucose control, medication adherence, and diabetes self-management behaviors) during active cancer treatment is hypothesized as an explanation for worse outcomes among diabetic cancer patients. The objective of this systematic review is to determine and quantify how a cancer diagnosis impacts diabetes management. ...
American Journal of Clinical Oncology - Current Issue
04:59
National Burden of Hospitalization Due to Cutaneous Melanoma in Adolescents and Young Adults
Objectives: Although adolescents and young adults (AYA) suffer disproportionately from cutaneous melanoma (CM), little is known regarding the burden of CM leading to hospitalization in AYA. The objective of this study was to elucidate sociodemographic/hospitalization characteristics of AYA CM inpatients, determine which factors lead to the greater length of stay (LOS) and cost of care for AYA CM inpatients, and evaluate trends in the prevalence, LOS, and cost of care for AYA CM hospitalizations. ...
American Journal of Clinical Oncology - Current Issue
04:59
Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer?
Objectives: In endometrial cancer, the appropriate sequence of adjuvant chemotherapy (aCT) and adjuvant radiation therapy (aRT) is unclear. We aim evaluated whether early chemotherapy is associated with improved overall survival (OS) and cancer-specific survival (CSS). Methods: Endometrial cancer patients that received aCT and aRT were selected from the SEER-Medicare database. Early chemotherapy was defined as receiving aCT before aRT, with or without additional aCT (“sandwich” regimens)....
American Journal of Clinical Oncology - Current Issue
04:59
Cost-Effectiveness Analysis of Upfront SBRT for Oligometastatic Stage IV Non–Small Cell Lung Cancer Based on Mutational Status
Objectives: Current National Comprehensive Cancer Network (NCCN) guidelines support systemic therapy based on mutational status in stage IV non–small cell lung cancer (NSCLC), with stereotactic body radiation therapy (SBRT) reserved for oligoprogression. We aimed to evaluate the cost-effectiveness of the routine addition of SBRT to upfront therapy in stage IV NSCLC by mutational subgroup. Materials and Methods: A Markov state transition model was constructed to perform a cost-effectiveness...
American Journal of Clinical Oncology - Current Issue
04:59
Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R
Objectives: Insulin-like growth factor-methotrexate (IGF-MTX) is a conjugate of methotrexate and 765IGF, a variant of IGF-1 with high affinity for insulin-like growth factor type 1 receptor. The study aim was to determine the maximum tolerated dose of IGF-MTX in refractory solid organ and hematologic malignancies expressing insulin-like growth factor type 1 receptor. Materials and Methods: This phase I trial used a modified toxicity probability interval design with 5 cohort dose levels, and...
American Journal of Clinical Oncology - Current Issue
04:59
Intrapatient Molecular and Histologic Heterogeneity After First-generation or Second-generation TKI Therapy of NSCLC Patients: Potential Clinical Impact on Subsequent third-generation TKI Treatment
Objectives: The discovery of tyrosine kinase inhibitors (TKI) has remarkably improved the clinical course of patients with non–small cell lung cancer driven by Epidermal Growth Factor Receptor (EGFR) mutations. However, virtually in all cases, the disease resurfaces in a TKI-resistant form that is mainly linked to an acquired EGFR-T790M mutation, a MET amplification, or small cell lung cancer (SCLC) transformation. Third-generation TKIs are able to block tumor growth through an irreversible binding...
American Journal of Clinical Oncology - Current Issue
04:59
Incidence of Neonatal Neutropenia and Leukopenia After In Utero Exposure to Chemotherapy for Maternal Cancer
No abstract available
American Journal of Clinical Oncology - Current Issue
04:59
A Matter of Comprehensive Informed Consent: Short-Term Mortality Rates With Definitive Treatment Options in Elderly Stage I NSCLC
Background: Although lobectomy is the standard of care in stage I non–small cell lung cancer (NSCLC), medical comorbidities increase surgical risk in elderly patients. No population-based studies compare short-term mortality (STM) for surgery (STM-S), radiation (STM-R), and observation (STM-O) in elderly patients with stage I NSCLC. Methods: A total of 60,466 biopsy-proven stage I NSCLC cases diagnosed between 2004 and 2012 were retrieved from the Surveillance, Epidemiology, and End Results...
American Journal of Clinical Oncology - Current Issue
04:59
On the Importance of Rural Health: Mistaking a Forest for a Few Trees
No abstract available
American Journal of Clinical Oncology - Current Issue
04:59
Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
We previously showed that alterations in mTOR pathway genes were correlated with response to rapalog therapy in metastatic renal cell carcinoma (mRCC), when the analysis focused on extremes of response. Herein, we expand on the prior cohort and examine genetic correlations with rapalog response in a dataset not selected for extremes of response. Tumors from 58 patients from the phase III trial of temsirolimus and 51 local mRCC patients treated with rapalogs were studied. Somatic mutations were investigated...
Molecular Cancer Therapeutics Online First Articles
Fri Oct 25, 2019 17:30
18F-FAC PET visualizes brain-infiltrating leukocytes in a mouse model of multiple sclerosis
Brain-infiltrating leukocytes contribute to multiple sclerosis (MS) and autoimmune encephalomyelitis and likely play a role in traumatic brain injury, seizure, and stroke. Brain-infiltrating leukocytes are also primary targets for MS disease-modifying therapies. However, no method exists for non-invasively visualizing these cells in a living organism. 1-(2'-deoxy-2'-18F-fluoroarabinofuranosyl) cytosine (18F-FAC) is a PET radiotracer that measures deoxynucleoside salvage and accumulates preferentially...
The Journal of Nuclear Medicine (JNM)
Fri Oct 25, 2019 19:13
Multimodality Imaging of Inflammation and Ventricular Remodeling in Pressure Overload Heart Failure
Inflammation contributes to ventricular remodeling after myocardial ischemia, but its role in non-ischemic heart failure is poorly understood. Local tissue inflammation is difficult to assess serially during pathogenesis. While 18F-fluorodeoxyglucose (FDG) accumulates in inflammatory leukocytes which may identify inflammation in the myocardial microenvironment, it remains unclear whether this imaging technique can isolate diffuse leukocytes in pressure overload heart failure. We aimed to evaluate...
The Journal of Nuclear Medicine (JNM)
Fri Oct 25, 2019 19:13
Response prediction of 177Lu-PSMA-617 RLT using PSA, Chromogranin A, and LDH.
Neuroendocrine-like trans-differentiation of prostate cancer adenocarcinomas correlates with serum levels of Chromogranin A (CgA) and drives treatment resistance. Aim of this work was to evaluate whether CgA could serve as a response predictor for 177Lu-PSMA617 radio-ligand therapy (PSMA-RLT) in comparison to the established tumor markers. Methods: 100 consecutive patients with metastasized castration resistant prostate cancer (mCRPC) scheduled for PSMA-RLT were evaluated for prostate specific...
The Journal of Nuclear Medicine (JNM)
Fri Oct 25, 2019 19:13
Imaging Inflammation in Atherosclerosis with CXCR4-directed 68Ga-Pentixafor PET/CT - Correlation with 18F-FDG PET/CT
C-X-C motif chemokine receptor 4 (CXCR4) is expressed on the surface of various cell types involved in atherosclerosis, with a particularly rich receptor expression on macrophages and T cells. First pilot studies with 68Ga-Pentixafor, a novel CXCR4-directed positron emission tomography (PET) tracer, have shown promise to non-invasively image inflammation within atherosclerotic plaques. The aim of this retrospective study was to investigate the performance of 68Ga-Pentixafor PET/computed tomography...
The Journal of Nuclear Medicine (JNM)
Fri Oct 25, 2019 19:13
Evaluation of the predictive role of tumor immune infiltrate in HER2-positive breast cancer patients treated with neoadjuvant anti-HER2 therapy without chemotherapy
Purpose: Tumor infiltrating lymphocytes (TILs) are associated with benefit to trastuzumab and chemotherapy in early-stage HER2+ breast cancer (BC) patients. The predictive value of TILs, TIL subsets, and other immune cells in patients receiving chemotherapy-sparing lapatinib plus trastuzumab (LT) treatment is unclear. Experimental Design: H&E-stained slides (n=59) were used to score stromal (s-)TILs from pre-treatment biopsies of patients enrolled in the neoadjuvant TBCRC006 trial of 12-week...
Clinical Cancer Research Online First Articles
Fri Oct 25, 2019 15:53
Simultaneous endocrine expression and loss of melanoma markers in malignant melanoma metastases, a retrospective analysis
Abstract Malignant melanoma metastases are chameleons of histopathology. In 4 primary malignant melanomas and 20 melanoma metastases expression of S-100, HMB-45 and melan-A as melanoma markers and CD56, synaptophysin and chromogranin-A as neuroendocrine markers was retrospectively analyzed. While all primary tumors expressed all 3 melanoma markers 7/20 of melanoma metastases had lost at least one melanoma marker, one had lost all three markers. Conversely about half of the samples...
Pathology & Oncology Research
Fri Oct 25, 2019 03:00
Setup management for stereotactic body radiation therapy of patients with pancreatic cancer treated via the breath-hold technique
Publication date: Available online 25 October 2019Source: Practical Radiation OncologyAuthor(s): Roland Teboh Forbang, Senthamizhchelvan Srinivasan, Sweet Ping Ng, Maureen L. Aliru, Joseph M. HermanAbstractPurpose/ObjectivesActive Breathing Coordinator (ABC) (Elekta AB, Crawley, UK) is a motion management strategy for radiation treatment. During setup, aligning the patient to the bony spine alone does not necessarily lead to an accurate alignment to soft tissue targets and further adjustment is necessary....
Practical Radiation Oncology
03:25
Low dose versus high dose radiotherapy for the palliation of dysphagia from esophageal cancer: a multicenter retrospective cohort study
Publication date: Available online 24 October 2019Source: Practical Radiation OncologyAuthor(s): Bram D. Vermeulen, Paul M. Jeene, Jasmijn Sijben, Robin Krol, Heidi Rütten, Johannes A. Bogers, Pètra M. Braam, Peter D. SiersemaAbstractBackground and purposeClinical evidence regarding optimal radiation dose for palliation of dysphagia from esophageal cancer is generally lacking. In an effort to investigate optimal radiation dose, we assessed two different radiation schedules for palliation of dysphagia.Materials...
Practical Radiation Oncology
03:25
Case study: cochlear implantation in cochlear otospongiosis.
Related ArticlesCase study: cochlear implantation in cochlear otospongiosis. Cochlear Implants Int. 2019 Oct 23;:1-5 Authors: Marfatia H, Shah K, Pareek A, Chatterjee C, Goyal P Abstract Objective and importance: Cochlear implantation can be performed successfully in patients with otospongiosis of the temporal bone with the potential for excellent audiological outcomes and high patient satisfaction. The purpose of this case report is to highlight the...
British Cochlear Implant Group
03:25

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου